NMDA receptor-mediated mechanism of ketamine-induced facilitation of glutamatergic excitatory synaptic transmission

Brain Research

Volumn 953, Issue 1-2, 2002, Pages 272-275

  Narimatsu, Eichi ^a   Kawamata, Yurie ^a   Kawamata, Mikito ^a   Fujimura, Naoyuki ^a   Namiki, Akiyoshi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenergic receptor; Hippocampus; Ketamine; Synaptic transmission

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; ATROPINE; BETA ADRENERGIC RECEPTOR; BICUCULLINE; KETAMINE; METHYSERGIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; PHENTOLAMINE; PROPRANOLOL;

AMPLITUDE MODULATION; ANESTHESIA; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; FACILITATION; HIPPOCAMPUS; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; HIPPOCAMPUS; KETAMINE; MALE; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 0037145754     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03375-9     Document Type: Article

References (25)

1. 2 receptor activation potentiates N-methyl-D-aspartate receptor-mediated ion currents by a protein kinase C-dependent mechanism. J. Neurosci. Res. 45:1996;153-160.
2. Calabresi P., Centonze D., Gubellini P., Pisani A., Bernardi G. Acetylcholine-mediated modulation of striatal function. Trends. Neurosci. 23:2000;120-126.
3. Chen L., Huang L.Y. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron. 7:1991;319-326.
4. Collingridge G.L., Lester R.A. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 41:1989;143-210.
5. Corssen G., Miyasaka M., Domino E.F. Changing concepts in pain control during surgery: dissociative anesthesia with CI-581. A progress report. Anesth. Analg. 47:1968;746-759.
6. Davies S.N., Alford S.T., Coan E.J., Lester R.A., Collingridge G.L. Ketamine blocks an NMDA receptor-mediated component of synaptic transmission in rat hippocampus in a voltage-dependent manner. Neurosci. Lett. 92:1988;213-217.
7. Durieux M.E. Inhibition by ketamine of muscarinic acetylcholine receptor function. Anesth. Analg. 81:1995;57-62.
8. Freund T.F., Antal M. GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus. Nature. 336:1988;170-173.
9. Gage P.W., Robertson B. Prolongation of inhibitory postsynaptic currents by pentobarbitone, halothane and ketamine in CA1 pyramidal cells in rat hippocampus. Br. J. Pharmacol. 85:1985;675-681.
10. Huang C.C., Lin C.H., Gean P.W. Potentiation of N-methyl-D-aspartate currents by isoproterenol in the acutely dissociated rat amygdalar neurons. Neurosci. Lett. 253:1998;9-12.
11. Lacaille J.C., Harley C.W. The action of norepinephrine in the dentate gyrus: beta-mediated facilitation of evoked potentials in vitro. Brain Res. 358:1985;210-220.
12. Little H.J., Atkinson H.D. Ketamine potentiates the responses of the rat superior cervical ganglion to GABA. Eur. J. Pharmacol. 98:1984;53-59.
13. MacDonald J.F., Miljkovic Z., Pennefather P. Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J. Neurophysiol. 58:1987;251-266.
14. Maclver M.B., Mikulec A.A., Amagasu S.M., Monroe F.A. Volatile anesthetics depress glutamate transmission via presynaptic actions. Anesthesiology. 85:1996;823-834.
15. Marietta M.P., Way W.L., Castagnoli N. Jr., Trevor A.J. On the pharmacology of the ketamine enantiomorphs in the rat. J. Pharmacol. Exp. Ther. 202:1977;157-165.
16. Martin L.L., Bouchal R.L., Smith D.J. Ketamine inhibits serotonin uptake in vivo. Neuropharmacology. 21:1982;113-118.
17. Narimatsu E., Aoki M. Transient depression of excitatory synaptic transmission induced by adenosine uptake inhibition in rat hippocampal slices. Brain Res. 862:2000;284-287.
18. Ohtani M., Kikuchi H., Kitahata L.M., Taub A., Toyooka H., Hanaoka K., Dohi S. Effects of ketamine on nociceptive cells in the medial medullary reticular formation of the cat. Anesthesiology. 51:1979;414-417.
19. Orser B.A., Pennefather P.S., MacDonald J.F. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology. 86:1997;903-917.
20. 3H]prazosin binding sites in rat forebrain. Neurosci. Lett. 40:1983;221-226.
21. Segal M., Markram H., Richter-Levin G. Actions of norepinephrine in the rat hippocampus. Prog. Brain Res. 88:1991;323-330.
22. Smith D.J., Azzaro A.J., Turndorf H., Abbott S.B. The effect of ketamine HCl on the in vitro metabolism of norepinephrine in rat cerebral cortex tissue. Neuropharmacology. 14:1975;473-481.
23. Smith D.J., Pekoe G.M., Martin L.L., Coalgate B. The interaction of ketamine with the opiate receptor. Life Sci. 26:1980;789-795.
24. Southan A.P., Wann K.T. In vitro actions of ketamine and methohexitone in the rat hippocampus. Br. J. Anaesth. 63:1989;574-580.
25. Tohdoh Y., Narimatsu E., Kawamata M., Namiki A. The involvement of adenosine neuromodulation in pentobarbital-induced field excitatory postsynaptic potentials depression in rat hippocampal slices. Anesth. Analg. 91:2000;1537-1541.